These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 16024228)
1. Exploring Mycobacterium avium inhibition by macrocyclic compounds. David S; Barros V; Passos Guerra K; Delgado R Res Microbiol; 2005 Nov; 156(9):904-10. PubMed ID: 16024228 [TBL] [Abstract][Full Text] [Related]
2. In vitro effect of free and complexed indium(III) against Mycobacterium tuberculosis. David S; Barros V; Cruz C; Delgado R FEMS Microbiol Lett; 2005 Oct; 251(1):119-24. PubMed ID: 16137841 [TBL] [Abstract][Full Text] [Related]
3. In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium. De Logu A; Saddi M; Onnis V; Sanna C; Congiu C; Borgna R; Cocco MT Int J Antimicrob Agents; 2005 Jul; 26(1):28-32. PubMed ID: 15955675 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones. Cai S; Sato K; Shimizu T; Yamabe S; Hiraki M; Sano C; Tomioka H J Antimicrob Chemother; 2006 Jan; 57(1):85-93. PubMed ID: 16303883 [TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
6. The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient. Viveiros M; Martins M; Couto I; Kristiansen JE; Molnar J; Amaral L In Vivo; 2005; 19(4):733-6. PubMed ID: 15999542 [TBL] [Abstract][Full Text] [Related]
7. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. García-García A; Gálvez J; de Julián-Ortiz JV; García-Domenech R; Muñoz C; Guna R; Borrás R J Antimicrob Chemother; 2004 Jan; 53(1):65-73. PubMed ID: 14645324 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, spectral studies and antibacterial activity of novel macrocyclic Co(II) compounds. Reddy PM; Prasad AV; Shanker K; Ravinder V Spectrochim Acta A Mol Biomol Spectrosc; 2007 Nov; 68(3):1000-6. PubMed ID: 17553737 [TBL] [Abstract][Full Text] [Related]
9. Intracellular activity of azithromycin against Mycobacterium avium complex in human macrophages. Wildfeuer A; Haberreiter A Arzneimittelforschung; 1997 Jul; 47(7):866-8. PubMed ID: 9272246 [TBL] [Abstract][Full Text] [Related]
10. Syntheses and biological activity of amamistatin B and analogs. Fennell KA; Möllmann U; Miller MJ J Org Chem; 2008 Feb; 73(3):1018-24. PubMed ID: 18173285 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial and antifungal activity of acyclic and macrocyclic uracil derivatives with quaternized nitrogen atoms in spacers. Semenov VE; Voloshina AD; Toroptzova EM; Kulik NV; Zobov VV; Giniyatullin RK; Mikhailov AS; Nikolaev AE; Akamsin VD; Reznik VS Eur J Med Chem; 2006 Sep; 41(9):1093-101. PubMed ID: 16762461 [TBL] [Abstract][Full Text] [Related]
12. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis. De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992 [TBL] [Abstract][Full Text] [Related]
13. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
14. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs. Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465 [TBL] [Abstract][Full Text] [Related]
16. Various colony-formers of Mycobacterium avium-intracellulare. Kuze F; Uchihira F Eur J Respir Dis; 1984 Aug; 65(6):402-10. PubMed ID: 6468543 [TBL] [Abstract][Full Text] [Related]
17. Physicochemical and biological characterization of novel macrocycles derived from o-phthalaldehyde. Reddy PM; Ho YP; Shanker K; Rohini R; Ravinder V Eur J Med Chem; 2009 Jun; 44(6):2621-5. PubMed ID: 18996622 [TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
20. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis. Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]